Search Results

A Review of the Efficacy and Safety of Genvoya® (Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide) in the Management of HIV-1 Infection.

• Authors : Angione SA; 1 School of Pharmacy and Health Sciences, Fairleigh Dickinson University, Florham Park, NJ, USA.; Cherian SM

Subjects: Disease Management*; Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*therapeutic use ; Cobicistat/Cobicistat/Cobicistat/*therapeutic use

• Source: Journal of pharmacy practice [J Pharm Pract] 2018 Apr; Vol. 31 (2), pp. 216-221. Date of Electronic Publication: 2017 May 30.Publisher: Sage Publications Country of Publication: United States NLM ID: 8900945 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

HIV treatment simplification to elvitegravir/cobicistat/emtricitabine/tenofovir disproxil fumarate (E/C/F/TDF) plus darunavir: a pharmacokinetic study.

• Authors : Harris M; British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada. .; AIDS Research Program, St. Paul's Hospital, Vancouver, BC, Canada. .

Subjects: Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*therapeutic use ; Cobicistat/Cobicistat/Cobicistat/*pharmacokinetics ; Darunavir/Darunavir/Darunavir/*pharmacokinetics

• Source: AIDS research and therapy [AIDS Res Ther] 2017 Nov 02; Vol. 14 (1), pp. 59. Date of Electronic Publication: 2017 Nov 02.Publisher: BioMed Central Country of Publication: England NLM ID: 101237921 Publication Model: Electronic Cited Medium: Internet ISSN: 1742-6405

Record details

Tenofovir alafenamide, emtricitabine, elvitegravir, and cobicistat combination therapy for the treatment of HIV.

• Authors : Imaz A; a HIV and STD Unit, Department of Infectious Diseases , Bellvitge University Hospital, Bellvitge Biomedical Research Institut (IDIBELL) , Barcelona , Spain.; Podzamczer D

Subjects: Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*therapeutic use ; Cobicistat/Cobicistat/Cobicistat/*therapeutic use ; Emtricitabine/Emtricitabine/Emtricitabine/*therapeutic use

• Source: Expert review of anti-infective therapy [Expert Rev Anti Infect Ther] 2017 Mar; Vol. 15 (3), pp. 195-209. Date of Electronic Publication: 2017 Feb 08.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101181284 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide for the treatment of HIV in adults.

• Authors : Bonora S; a Unit of Infectious Diseases, Department of Medical Sciences , University of Torino , Torino , Italy.; Calcagno A

Subjects: Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*therapeutic use ; Cobicistat/Cobicistat/Cobicistat/*therapeutic use ; Emtricitabine/Emtricitabine/Emtricitabine/*therapeutic use

• Source: Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2016; Vol. 17 (3), pp. 409-19.Publisher: Informa Healthcare Country of Publication: England NLM ID: 100897346 Publication Model: Print Cited Medium: Internet ISSN: 1744-7666

Record details

Inflammatory pseudotumor associated with HSV infection of rectal vascular endothelium in a patient with HIV: a case report and literature review.

• Authors : Bai, Shi; Maykel, Justin A.; Yang, Michelle X.

• Source: BMC Infectious Diseases. March 19, 2020, Vol. 20 Issue 1.

Record details

Assessing the lymphoid tissue bioavailability of antiretrovirals in human primary lymphoid endothelial cells and in mice.

• Authors : Dyavar, Shetty Ravi; Gautam, Nagsen; Podany, Anthony T

Subjects: LYMPHOID tissue; EMTRICITABINE; ENDOTHELIAL cells

• Source: Journal of Antimicrobial Chemotherapy (JAC); Oct2019, Vol. 74 Issue 10, p2974-2978, 5p

Record details

Bioequivalence of the Once‐Daily Single‐Tablet Regimen of Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide Compared to Combined Intake of the Separate Agents and the Effect of Food on Bioavailability.

• Authors : Crauwels, Herta M.; Baugh, Bryan; Landuyt, Erika

Subjects: BIOAVAILABILITY; TENOFOVIR; HIV

• Source: Clinical Pharmacology in Drug Development; May2019, Vol. 8 Issue 4, p480-491, 12p

Record details

Comparative study of antiretroviral drug regimens and drug-drug interactions between younger and older HIV-infected patients at a tertiary care teaching hospital in South Korea

• Authors : Park, Mi Seon; Yang, Young-Mo; Kim, Ju-Sin

• Source: Therapeutics and Clinical Risk Management. Annual, 2018, Vol. 14, p2229, 13 p.

Record details

Darunavir-cobicistat-emtricitabine-tenofovir alafenamide: safety and efficacy of a protease inhibitor in the modern era

• Authors : Squillace, Nicola; Bozzi, Giorgio; Colella, Elisa

• Source: Drug Design, Development and Therapy. Annual, 2018, Vol. 10, p3635, 9 p.

Record details

HIV/HCV therapy with ledipasvir/sofosbuvir after randomized switch to emtricitabine-tenofovir alafenamide-based single-tablet regimens.

• Authors : Huhn, Gregory D.; Ramgopal, Moti; Jain, Mamta K.

• Source: PLoS ONE. January 29, 2020, Vol. 15 Issue 1, e0224875.

Record details